Merck & Company Inc revenue growth has been varied year-over-year.

What is MRK's revenue growth rate?

Historical revenue data is available for Merck & Company Inc to analyze growth trends.

How fast is MRK earnings growing?

Earnings growth data is available for Merck & Company Inc analysis.

What is MRK's profit margin?

Profit margin data is available for Merck & Company Inc.

MRK Revenue & Earnings Growth Analysis 2026 - Is Merck & Company Inc Growing?

Growth Summary

Merck & Company Inc (MRK) has experienced challenges in growth. The company operates in the Healthcare sector, specifically in the Drug Manufacturers - General industry.

Over the past 4 years, Merck & Company Inc has achieved a revenue compound annual growth rate (CAGR) of 2.0%, while earnings have grown at 165.9% CAGR.

Latest Revenue

$65.01B

Net Income

$18.25B

5-Year Revenue CAGR

2.0%

4 years of data

Net Margin

N/A

Latest period

Revenue Growth Over Time

Historical revenue and profitability trends for Merck & Company Inc

The chart above illustrates Merck & Company Inc's revenue trajectory over the past 4 years. The revenue pattern shows the challenges the company has faced in recent periods.

Year-over-Year Growth Rates

Annual percentage change in revenue and earnings

Growth rates provide insight into the momentum of Merck & Company Inc's business.

Profit Margin Trends

How efficiently Merck & Company Inc converts revenue into profit

Understanding Profit Margins

Profit margins reveal how much of each dollar of revenue Merck & Company Inc retains at different stages:

Gross Margin (N/A%): What remains after direct production costs
Operating Margin (N/A%): Profit from core operations before interest and taxes
Net Margin (N/A%): Final profit after all expenses

Future Growth Outlook

Analyst estimates and forward-looking indicators

EPS Estimate 2026

$5.13

Current: $7.30

EPS Estimate 2027

$9.79

90.7% expected growth

Price Target

$126.57

Analyst consensus

What Analysts Are Saying

Wall Street analysts project Merck & Company Inc to continue growing earnings in the coming year. The consensus analyst rating is 4.0385 based on 26 analysts.

Growth Analysis Conclusion

Based on our comprehensive analysis, Merck & Company Inc (MRK) demonstrates declining growth characteristics.

Key Takeaways:

Revenue Growth:, 2.0% CAGR over 4 years
Profitability: demonstrates the company is profitable
Efficiency:

Investment Considerations

This growth analysis provides a comprehensive view of Merck & Company Inc's historical performance and future outlook. Investors should consider these growth metrics alongside valuation, competitive positioning, and broader market conditions when making investment decisions. Past performance does not guarantee future results.